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Abstract
There has been growing interest in proteomics in the
last ten years. Its fields of  application are still emerg-
ing and include application to a wide spectrum of  lung
diseases. In this context the proteomic approach has
been directed especially to the study of  broncholveo-
lar lavage (BAL) protein composition, with the aim
of  obtaining insights into the pathogenetic mecha-
nisms of lung diseases and of identifying possible dis-
ease-specific biomarkers. Proteomic analysis is com-
plex and produces a great mass of  data, even more
than genomics.Many techniques are available today for
Proteomics provides much information on
gene products and post-translational modi-
fications, it is therefore complementary to
genomics and enables protein composition
in body fluids, cells and tissues to be investi-
gated under different conditions1,2. Proteom-
ic analysis is complex and produces a great
mass of  data, even more than genomics. It
is really like an ocean with many different
fishes, or proteins, to catch!
There has been growing interest in proteom-
ics in the last ten years following the genom-
ic era1-4. Its fields of application are still
emerging and include the study of a wide
spectrum of  lung diseases : interstitial lung
diseases, asthma, occupational lung diseas-
es, acute lung injury, lung cancer, cystic fi-
brosis, chronic lung rejection, etcs.2,3,5-8. In
this context the proteomic approach has
been directed especially to the study of bron-
cholveolar lavage (BAL) protein composi-
tion, with the aim of obtaining insights into
the pathogenetic mechanisms and of  identi-
fying possible disease-specific biomarkers9-15.
Many techniques are available today for a
proteomic approach and some of  them have
a proteomic approach and they can be applied to BAL.
Each has advantages and disadvantages. Critical points
to be considered before planning research in this field
are: appropriate experimental design, reproducible
methods and suitable statistical analysis. This means a
multidisciplinary approach, exploiting molecular bi-
ology, clinical and bioinformatics expertise, is need-
ed. Here we report a summary of  recent literature on
proteomics in BAL and of  our experience in this field.
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ben applied to BAL analysis. Each has ad-
vantages and disadvantages1,2,4,5,14-16. Their
complexity and rapid expansion call for great
care and competence, because production of
useless data is to be avoided and subsequent
confirmation and validation of  results must
be done. The need to develop guidelines to
ensure high quality data required by this type
of  approach has been recently pointed
out17.Critical points to be considered before
planning research in this field are: appropri-
ate experimental design, reproducible meth-
ods and suitable statistical analysis. This
means a multidisciplinary approach, exploit-
ing molecular biology, clinical and bioinfor-
matics expertise, is needed. Experimental
protocol must include not only appropriate
techniques but also provide the number of
samples needed to obtain meaningful data.
The distribution of  results (normal or
skewed) must be carefully determined, and
if  necessary transformed, before statistical
analysis is applied. This aspect is crucial for
differential display of  proteins and for iden-
tifying biomarkers, because correct statisti-
cal analysis makes it possible to determine
whether differences in protein expression in
groups of  diseases are significant or wheth-
er they are only an effect of  variability of
the sample5,18-19.
The state of  the art of  BAL proteomics has
been the topic of some recent reviews un-
derlining the growing interest in this
field1,15,16,19. We also recently wrote a review
on the application of  proteomics to BAL
analysis considering all the methodological
aspects and the studies performed in vari-
ous lung diseases20. Most of  the data availa-
ble so far regards protein composition in
BAL fluid, the cellular component has been
less investigated1,20.
BAL fluid has some limitations, that should
be considered, for proteomic analysis, they
are: high salt concentrations, dilution and low
protein concentration, abundance of plas-
ma high Mw proteins, but they can be at least
partially corrected by appropriate expedients
according to the experimental design and the
techniques used (dyalisis, concentration of
the sample, removal of  high Mw
proteins,etc).Therefore sample preparation
can introduce significant analytical variabili-
ty and the study completeness also depends
on correct sample processing2,5,15,17,20-22.
The groups of  Lenz, Lindahl, Wattiez,
Grunewald and ours were among the first
to work in this field and to give a relevant
contribute to the identification of  BAL pro-
teins with the aims to realise a database and/
or to characterize disease specific protein
patterns7,9-14. Our experience with this tech-
nique began around 1996 with the collabo-
ration with the Proteomic Laboratory of  the
Molecular Biology Dept. in Siena Universi-
ty. We studied serum and BAL from patients
with sarcoidosis (S) pulmonary fibrosis as-
sociated with systemic sclerosis (SSc) and
idiopathic pulmonary fibrosis (IPF), three
interstitial lung diseases (ILD) characterized
by different pathogenesis and evolution9,13,23.
Proteins were separated by high resolution
2D-electrophoresis (2D-E) and then identi-
fied by gel matching, immunoblotting and
especially mass spectrometry ( MALDI TOF
MS)13. 2D- electrophoresis application to
BAL provides much information on protein
composition and allows simultaneous display
of  proteins present in alveolar spaces, but to
obtain suitable data a particular attention
must be given to appropriate sample process-
ing and loading and to the correct staining
of  the gel. In two-dimensional electrophore-
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sis (2-DE), polypeptides are first separated
according to their isoelectric point and then
by their molecular weight. After staining, the
2D-E gels from different samples can be
compared (differential display proteomics),
for identifying disease specific protein pat-
terns20,21. Therefore we assessed carefully the
method to obtain reproducible and compa-
rable results13,24,25 (Fig. 1).
According to our experience the most inter-
esting findings were in BAL, where we found
huge amount of  plasma and locally produced
proteins (800-1000 spots /gel). 85 proteins
were identified, 38 for the first time in BAL.
They had different origins (plasma derived,
locally secreted, or products of  cell damage
and proteolytic activity) and functions (e.g.
antiprotease, anti- or proinflammatory, anti-
oxidant, cell growth or coagulation related
or unknown ). The percentage volumes of
the identified spots were calculated and com-
pared among sarcoidosis, SSc and IPF, then
groups of  proteins expressed in significant-
ly different amount were found13,24. There-
fore the three diseases were characterized by
different protein profile in line with their
different pathogenesis. An increase in plas-
ma proteins was expecially found in S com-
pared to IPF, while in IPF a greater abun-
dance of  a group of  low molecular weight
proteins was present compared to S. SSc
showed a profile with characteristics inter-
mediate between the two other diseases, there
were up and down regulated proteins in dif-
ferent proportions. We have also compared
BAL protein percentage volumes in the three
ILD with those of  a control group and sig-
nificant differences were found in some pro-
tein expression (paper in preparation ). We
identified groups of  proteins of  interest that
we are now investigating by easier and faster
methods, such as ELISA, in a greater number
of  cases, for possible biomarkers of  disease.
They are low molecular weight proteins with
various, not completely known, functions,
potentially involved in pulmonary fibrosis
pathogenetic mechanisms, especially in fi-
broblast proliferation and activation, tissue
remodeling, oxidant-antioxidant and pro-
tease-antiprotease systems13,24. MIF is one of
these proteins and ELISA confirmed that it
is significantly increased in IPF compared to
controls (paper ready to be submitted).
The role of  the imbalance between protease/
antiprotease and oxidant/antioxidant in tis-
sue damage is well known, so we also inves-
tigated oxidative stress by a proteomic ap-
proach. The identification of  protein targets
of  oxidation by proteomic analysis (2-DE
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Fig. 1 – Silver stained 2D-Electrophoresis gel from BAL of
an patient with IPF. 45 ìg of BAL sample were loaded . The
BALF sample was dialysed against water, lyophilised and
dissolved in lysis buffer so that 100 ml contained 45 mg
proteins. Two-dimensional gel electrophoresis (2D-E) was
performed as described by us (13,24).Electrophoretogram
images were obtained with a computing densitometer
(Molecular Dynamics 300S) and processed with the Melanie
IV computer system . Quantitative variations in proteins
were expressed as relative volumes of spots (% volume).
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combined with immunoblotting with specific
antibodies for carbonyl groups) suggested
that carbonylation involved a limited number
of  carbonylation-sensitive proteins (mainly
albumin, AAT, IgG heavy chains and com-
plement components) in the three diseases
and controls, whereas a greater number of
oxidized proteins with various functions was
found only in IPF26. Therefore proteomics
allows to identify in BAL proteins that un-
derwent structural changes locally, loosing
their original function and in some circum-
stances acquiring a new one with a possible
role in the pathogenesis of  the disease. This
could happen for oxidized, fragmented or
polymerized proteins that we have found in
BAL in ILD13,23,26.
Sarcoidosis BAL has been also studied by
other techniques such as narrow range pH
gradients that allow to better analyze regions
of  interest14,27, or by SELDI TOF MS that
seems to facilitate the discovery of  disease
related protein profiles28 Surface-enhanced
laser desorption/ionization-time-of-flight
mass spectroscopy enabled determination of
protein patterns in sarcoidosis BAL fluid and
allowed detection of  protein patterns linked
to a particular disease course28.
Proteomic analysis of  BAL has been also
applied to BAL of  patients with obstructive
lung diseases such as COPD and asth-
ma15,22,29,30. It was performed in allergic asth-
matic patients after segmental allergen chal-
lenge using affinity depletion of  six abundant
BAL proteins, SDS-PAGE separation,
HPLC combined with mass spectrometry for
protein identification and semiquantitation
(SAC).By these methods a huge number of
proteins was identified, some of  which were
expressed differently in challenged asthmat-
ic patients versus controls29. This wide data-
base of  BAL proteins may be useful to iden-
tify new diagnostic markers of  asthma and
to complete the BAL protein composition.
A proteomic approach has been applied to
the study of  fibroblasts in BAL from patients
with mild asthma compared to control sub-
jects Differential expression patterns be-
tween the fibroblasts in the two groups in
motility-regulating proteins were identified
by two-dimensional electrophoresis and mass
spectrometry30. Some researchers from this
group have developed and validated novel
technology applications that can be used to
characterize the patterns of  global protein
expression in tissue and biofluids in either
gel-based systems or by automated multidi-
mensional nanocapillary liquid chromatog-
raphy22. Moreover very recently applying a
technology toolbox consisting of  replicate
2-dimensional gel separations, image anno-
tation, and mass spectrometry identification,
they found protein expression patterns as-
sociated with progression of  COPD in BAL
of  smokers31.
In conclusion, BAL proteomics has passed
fom the pioneering stage to a high level of
optimization in sample preparation and in
the use of  new techniques to separate and
identify proteins. They include advanced MS
and gel electrophoresis, bioinformatics, au-
tomation and miniaturization, that permit
high sample throughput analysis with im-
proved sensitivity and reproducibility. There-
fore a proteomic approach applied to the
study of  BAL can help to characterize the
complex alveolar microenvironment, impor-
tant for a better understanding of  pathoge-
netic mechanisms, and to identify groups of
disease-related proteins, useful for the future
identification of diagnostic and prognostic
markers, or for new advances in therapy.
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